SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 30 Dec 2021
Last Applicant/ Owned by
90 Kerry Place
Norwood
MA
02062
Serial Number
86220538 filed on 13th Mar 2014
Registration Number
4842066 registered on 27th Oct 2015
Correspondent Address
James David Johnson
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
MEDFX
Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes
First Use Date in General
15th Aug 2013
First Use Date in Commerce
15th Aug 2013
Mark Details
Serial Number
No 86220538
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 59914-0006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Oct 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 30th Dec 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 30th Dec 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 29th Dec 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 27th Sep 2021 | TEAS SECTION 8 & 15 RECEIVED |
| 27th Oct 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 27th Oct 2015 | REGISTERED-PRINCIPAL REGISTER |
| 24th Sep 2015 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 23rd Sep 2015 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 21st Sep 2015 | STATEMENT OF USE PROCESSING COMPLETE |